{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:38:25Z","timestamp":1781876305562,"version":"3.54.5"},"reference-count":36,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal hyperinflammatory condition. It may occur as a primary (genetic) condition due to mutations in genes important in the cytolytic secretory pathway that cause perforin and granzymes to induce apoptosis in target cells. Primary HLH is divided into familial HLH (FHLH1-5), in which HLH is the only manifestation of disease, and other genetic causes in which HLH is one of several clinical manifestations. The identical clinical findings may arise secondary to infectious, rheumatologic, malignant, or metabolic conditions. Whether primary or secondary, HLH therapy needs to be instituted promptly to prevent irreversible tissue damage. It is helpful to think of HLH as the severe end of the spectrum of hyperinflammatory disorders when the immune system starts to damage host tissues (immunopathology). Therefore, no single clinical feature alone is diagnostic for HLH, and it is important that the entire clinical presentation be considered in making the diagnosis. This article contains a discussion of the genetic background, clinical presentation, diagnostic dilemmas, and features that are helpful in making the diagnosis of HLH, along with a discussion of common problems in its management.<\/jats:p>","DOI":"10.1182\/asheducation-2011.1.178","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T20:33:13Z","timestamp":1323289993000},"page":"178-183","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":145,"title":["Approach to Hemophagocytic Syndromes"],"prefix":"10.1182","volume":"2011","author":[{"given":"Sheila","family":"Weitzman","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, The Hospital for Sick Children, Toronto, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111717142033500_B1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0029-1237386","article-title":"Hemophagocytic lymphohistiocytosis: when the immune system runs amok","volume":"221","author":"Janka","year":"2009","journal-title":"Klin Padiatr"},{"key":"2019111717142033500_B2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1651-2227.1991.tb11878.x","article-title":"Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis","volume":"80","author":"Henter","year":"1991","journal-title":"Acta Paediatr Scand"},{"key":"2019111717142033500_B3","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"2019111717142033500_B4","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.bbmt.2009.11.014","article-title":"Histiocytic disorders: Recent Insights into pathophysiology and practical guidelines","volume":"16","author":"Filipovich","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019111717142033500_B5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(06)68232-9","article-title":"Cytotoxic therapy for severe avian influenza A (H5N1) infection","volume":"367","author":"Henter","year":"2006","journal-title":"Lancet"},{"key":"2019111717142033500_B6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/eci.09.58","article-title":"Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy","volume":"6","author":"Gupta","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"2019111717142033500_B7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/asheducation-2009.1.127","article-title":"Hemophagocytic lymphohistiocytosis (HLH) and related disorders","author":"Filipovich","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2019111717142033500_B8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00443367","article-title":"Familial erythrophagocytic lymphohistiocytosis","volume":"140","author":"Janka","year":"1983","journal-title":"Eur J Pediatr"},{"key":"2019111717142033500_B9","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"key":"2019111717142033500_B10","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1182\/blood-2010-04-282392","article-title":"Reduced intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"},{"key":"2019111717142033500_B11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MPH.0b013e3181f84a52","article-title":"Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010","volume":"33","author":"Imashuku","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"2019111717142033500_B12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/pbc.21681","article-title":"High ferritin levels and the diagnosis of HLH\/Sepis\/SIRS\/MODS\/MAS","volume":"51","author":"Castillo","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"2019111717142033500_B13","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pbc.21423","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"2019111717142033500_B14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0609.2004.00318.x","article-title":"Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome","volume":"74","author":"Schaer","year":"2005","journal-title":"Eur J Haematol"},{"key":"2019111717142033500_B15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2141.2007.06922.x","article-title":"Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis","volume":"140","author":"Horne","year":"2008","journal-title":"Br J Haematol"},{"key":"2019111717142033500_B16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor a-chain in macrophage activation syndrome and unrelated new-onset systemic juvenile idiopathic arthritis","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2019111717142033500_B17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jhep.2007.05.014","article-title":"Soluble CD163 from activated macrophages predicts mortality in acute liver failure","volume":"47","author":"M\u00f8ller","year":"2007","journal-title":"J Hepatol"},{"key":"2019111717142033500_B18","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2006-04-015693","article-title":"Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease","volume":"108","author":"Marcenaro","year":"2006","journal-title":"Blood"},{"key":"2019111717142033500_B19","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2007-02-074468","article-title":"Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagoctic lymphohistiocytosis 4 (FHL4) patients","volume":"110","author":"Bryceson","year":"2007","journal-title":"Blood"},{"key":"2019111717142033500_B20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"2019111717142033500_B21","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1542\/peds.2006-3164","article-title":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymoctye globulins: a single-center retrospective report of 38 patients","volume":"120","author":"Mahlaoui","year":"2007","journal-title":"Pediatrics"},{"key":"2019111717142033500_B22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/bmt.2008.133","article-title":"Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis","volume":"42","author":"Baker","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"2019111717142033500_B23","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1542\/peds.2005-1789","article-title":"Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients","volume":"117","author":"Ouach\u00e9e-Chardin","year":"2006","journal-title":"Pediatrics"},{"key":"2019111717142033500_B24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1203\/00006450-199810000-00001","article-title":"Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives","volume":"44","author":"Sullivan","year":"1998","journal-title":"Pediatr Res"},{"key":"2019111717142033500_B25","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2001.19.10.2665","article-title":"Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"19","author":"Imashuku","year":"2001","journal-title":"J Clin Oncol"},{"key":"2019111717142033500_B26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MPH.0b013e3180f61be3","article-title":"Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"29","author":"Balamuth","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"2019111717142033500_B27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0609.2007.00868.x","article-title":"Immunophenotypic analysis of Epstein-Barr virus (EBV)-infected CD8+ T cells in a patient with EBV-associated hemophagocytic lymphohistiocytosis","volume":"79","author":"Wada","year":"2007","journal-title":"Eur J Haematol"},{"key":"2019111717142033500_B28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1017\/CBO9780511545252.019","article-title":"Clinical aspects and therapy of hemophagocytic lymphohistiocytosis","volume-title":"Histiocytic Disorders of Children and Adults","author":"Janke","year":"2005"},{"key":"2019111717142033500_B29","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/MPH.0b013e3181864ab9","article-title":"Hemophagocytic lymphohistiocytosis onset during induction therapy for precursor B-cell acute lymphoblastic leukemia","volume":"30","author":"Breakey","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"2019111717142033500_B30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/pbc.22688","article-title":"Hemophagocytic lymphohistiocytosis associated with B precursor Acute lymphoblastic leukemia","volume":"56","author":"Kelly","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"2019111717142033500_B31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/pbc.22846","article-title":"Hemophagocytic lymphohistiocytosis with MUNC 13.4 gene mutation or reduced Natural Killer cell function prior to the onset of childhood leukemia","volume":"56","author":"Chang","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"2019111717142033500_B32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.clim.2005.06.006","article-title":"Healing hemophagocytosis","volume":"117","author":"Filipovich","year":"2005","journal-title":"Clin Immunol"},{"key":"2019111717142033500_B33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/08880010701640499","article-title":"Systemic type Epstein-Barr virus-related lymphoproliferative diseases in children and young adults: challenges for pediatric hemato-oncologists and infectious disease specialists","volume":"24","author":"Imashuku","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"2019111717142033500_B34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ajh.21236","article-title":"Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis","volume":"83","author":"Olin","year":"2008","journal-title":"Am J Hematol"},{"key":"2019111717142033500_B35","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1086\/323675","article-title":"The role of infections in primary hemophagocytic lymphohistiocytosis: a case series and review of the literature","volume":"33","author":"Sung LWeitzman","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2019111717142033500_B36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of hemophagocytic lymphohistiocytosis in Japan","volume":"86","author":"Ishii","year":"2007","journal-title":"Int J Hematol"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2011\/1\/178\/1494096\/bep00111000178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2011\/1\/178\/1494096\/bep00111000178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T11:30:31Z","timestamp":1593343831000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2011\/1\/178\/96973\/Approach-to-Hemophagocytic-Syndromes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2011.1.178","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,10]]}}}